NHS

Pharma

U.K. shuns immunocompromised, saying it won't buy AZ's Evusheld

The U.K. said it will not purchase AZ's Evusheld, citing “insufficient data” on the duration of protection it provides vs. omicron and its subvariants
Kevin Dunleavy Aug 15, 2022 11:35am

NICE green lights PrEP treatment for prevention of HIV

Dec 15, 2021 10:45am

Costly decision: NICE rejects Pfizer heart disease drug Vyndaqel

May 12, 2021 10:01am

Amid Vertex-NHS deadlock, UK pharma lobby touts pricing teamwork

Jun 12, 2019 11:46am

NICE flip-flops to back Ionis rare disease treatment Tegsedi

Apr 16, 2019 11:15am

NICE issues preliminary ‘no’ on Alnylam’s and Ionis’ ATTR drugs

Dec 12, 2018 12:26pm